R21042827 |
Pidotimod |
Pidotimod is an immunostimulant. It is a synthetic dipeptide with immunomodulato
|
R21042828 |
Riluzole |
Riluzole is an anticonvulsant and belongs to a use-dependent family of sodium ch
|
R21042829 |
vericiguat |
Vericiguat (BAY1021189) is a potent, orally active, soluble guanylate cyclase st
|
R21042830 |
CA-4948 |
NA
|
R21042831 |
Eribulin mesylate |
Eribulin mesylate is an anticancer agent targeting microtubules for the treatmen
|
R21042832 |
ACT-389949 |
ACT-389949 is a pioneering, highly effective and selective formyl peptide recept
|
R21042833 |
PK-10571 |
|
R21042834 |
PXS-55505 2HCl |
|
R21042835 |
GSK620 |
|
R21042836 |
Tanespimycin (17-AAG; NSC330507; CP 127374) |
17-AAG is an effective inhibitor of Hsp90 with an IC50 of 5 nM. The binding affi
|
R21042837 |
Alvespimycin (hydrochloride);17-DMAG HCl |
Alvespimycin Hydrochloride is a potent inhibitor of HSP90 with an EC50 of 62±29
|
R21042838 |
Rhosin hydrochloride |
Rhosin hydrochloride is a specific inhibitor of Rho, and the KD value of binding
|
R21042839 |
MK-8719 |
MK-8719 is a highly effective and selective O-GlcNacase (OGA) inhibitor (Hoga Ki
|
R21042841 |
BMS-P5 |
BMS-P5 is a novel Peptidylarginine Deiminase 4 (PAD4) inhibitor that blocks del
|
R21042842 |
U18666A |
U18666A, a cell permeable drug, is an inhibitor of cholesterol synthesis and tra
|
R21042843 |
Luzindole |
Luzindole (N-0774) is a selective melatonin receptor antagonist.Luzindole prefer
|
R21042844 |
Elexacaftor |
CFTR Corrector 1 (Compound 1) is a compound modulator of the transmembrane condu
|
R21042845 |
YKL-05-099 |
YKL-05-099 is a salt-induced kinase (SIK) probe.The IC50 value of SIK2 inhibitio
|
R21042846 |
DTHIB |
|
R21042847 |
LSZ102 |
LSZ-102 is a potent, orally biopotent, selective estrogen receptor depressant wi
|
R21042848 |
Calcein-AM |
Calcein-AM is a permeable fluorescent dye used to measure cell viability.
|
R21042849 |
AZD-4205 |
AZD-4205 is a selective JAK1 inhibitor with an IC50 value of 73 nM and a weak in
|
R21042850 |
AZD9977 |
AZD9977 is a novel, first-rate, selective and oral glucocorticoid receptor (MR)
|
R21042851 |
AZD 5718 |
AZD5718 (AZD-5718, AZD5718) is a novel and effective inhibitor of 5-lipoxygenase
|
R21071201 |
AST5902 trimesylate |
AST5902 is the active metabolite of Alflutinib.
|